The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals
NCT04548492 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2020-09-14
Summary
In late 2019, a novel coronavirus, SARS-CoV-2, was identified as the causative agent of a cluster of pneumonia cases (COVID-19) in Wuhan, China. Clinical symptoms of COVID-19 may be mild or severe. The location where a person will self-isolate will be determined by their healthcare provider and their health authority. When determining the location, several factors to determine the suitability of the home setting are described as the case should stay in a room of their own so that they can be isolated from other household members. The rapid increase and evolution of modern mobile applications for communication and messaging for personal purposes have proved great benefit in healthcare management
Conditions
- the Use of Modern Technology Applications in Home Isolation
Interventions
- OTHER
-
Survey
to assess and validate how healthcare professionals can trigger or inhibit the use of modern technology applications in home isolation
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Min Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-14
- Primary Completion
- 2020-12-31
- Completion
- 2021-01-31
More Related Trials
-
Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19
NCT04973462 ·Status: UNKNOWN ·Phase: PHASE4
-
Persistence of Symptoms After Improvement of Acute COVID-19
NCT04764773 ·Status: COMPLETED
-
Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
NCT04260594 ·Status: COMPLETED ·Phase: PHASE4
-
A Simple Approach to Prevent Hospitalization for COVID-19 Patients
NCT04854824 ·Status: COMPLETED
-
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
NCT04535869 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
NCT04594343 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis
NCT04582331 ·Status: COMPLETED
-
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
NCT04395391 ·Status: COMPLETED
-
Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience
NCT04728880 ·Status: UNKNOWN
-
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
NCT06349655 ·Status: COMPLETED
-
Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)
NCT04443712 ·Status: UNKNOWN
-
Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals
NCT04349228 ·Status: WITHDRAWN ·Phase: PHASE3
-
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
NCT04523181 ·Status: COMPLETED ·Phase: PHASE2
-
Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient
NCT05386407 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
NCT04528927 ·Status: WITHDRAWN ·Phase: PHASE3
-
Use of a Hypochlorous Acid Spray Solution in the Treatment of COVID-19 Patients : COVICONTROL Study .
NCT05862480 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
NCT04738045 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19
NCT04582318 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
DAS181 for Severe COVID-19: Compassionate Use
NCT04324489 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.
NCT04729595 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
NCT04259892 ·Status: COMPLETED
-
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
NCT04466540 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China
NCT05682599 ·Status: UNKNOWN ·Phase: PHASE2
-
Administration of Chlorpromazine as a Treatment for COVID-19
NCT04354805 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Registry Study of Patients Hospitalized With Confirmed COVID-19
NCT05792865 ·Status: UNKNOWN